8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC
Society of Thoracic Surgeons - Surgeon
MAY 23, 2024
Dwight Owen (Ohio State University) discussed advances in biomarker testing and neoadjuvant immunotherapy for resectable non-small cell lung cancer. The Society’s 8 in 8 Series offers quick access to important topics in cardiothoracic surgery. No CME credit is associated with the viewing of web-based content. Duration 7 min.
Let's personalize your content